The historical rank and industry rank for OrbusNeich Medical Group Holdings's FCF Margin % or its related term are showing as below:
FRA:Q8T'
s FCF Margin % Range Over the Past 10 Years
Min: -1.54 Med: 10.07 Max: 15.76
Current: 0.6
During the past 7 years, the highest FCF Margin % of OrbusNeich Medical Group Holdings was 15.76%. The lowest was -1.54%. And the median was 10.07%.
FRA:Q8T's FCF Margin % is ranked better than 51.66% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.03
vs FRA:Q8T: 0.60
OrbusNeich Medical Group Holdings FCF Margin % Related Terms
OrbusNeich Medical Group Holdings FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OrbusNeich Medical Group Holdings FCF Margin % Chart
FRA:Q8T vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OrbusNeich Medical Group Holdings FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's FCF Margin % distribution charts can be found below:
* The bar in red indicates where OrbusNeich Medical Group Holdings's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OrbusNeich Medical Group Holdings (FRA:Q8T) has a FCF Margin % of 5.74% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on OrbusNeich Medical Group Holdings and its competitors. This is 43% below median its historical median of 10.07. According to the industry distribution chart, OrbusNeich Medical Group Holdings ranks #394 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 48.3%.
Is OrbusNeich Medical Group Holdings' FCF Margin % too high?
OrbusNeich Medical Group Holdings' current FCF Margin % of 5.74% is 43% below median its 10-year median of 10.07. Based on the distribution chart, OrbusNeich Medical Group Holdings ranks #394 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, OrbusNeich Medical Group Holdings has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does OrbusNeich Medical Group Holdings' FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, OrbusNeich Medical Group Holdings ranks #394 out of 815 companies for FCF Margin %. This puts OrbusNeich Medical Group Holdings in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on OrbusNeich Medical Group Holdings and its competitors. OrbusNeich Medical Group Holdings's current FCF Margin % is 5.74%, which is 43% below median its own 10-year median of 10.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrbusNeich Medical Group Holdings stock overvalued right now?
OrbusNeich Medical Group Holdings (FRA:Q8T) has a current FCF Margin % of 5.74%. The stock's GF Value™ is €0.47, compared to a current price of €0.37 — trading 22.1% below its estimated fair value. The current FCF Margin % is 5.74%, which is 43% below median its 10-year median of 10.07. OrbusNeich Medical Group Holdings' overall GF Score™ is 96/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For OrbusNeich Medical Group Holdings (FRA:Q8T), the current FCF Margin % is 5.74% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OrbusNeich Medical Group Holdings (FRA:Q8T) Overvalued in 2026?
Based on GuruFocus' analysis, OrbusNeich Medical Group Holdings stock appears to be undervalued.
The current stock price of €0.37 is trading 22.1% below its estimated GF Value™ of €0.47.
Key valuation signals for FRA:Q8T:
FCF Margin %: 5.74% (43% below median its 10-year median of 10.07)
GF Value™: €0.47 vs. price of €0.37 (22.1% below fair value)
No single metric tells the full story. See the FRA:Q8T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OrbusNeich Medical Group Holdings Business Description
OrbusNeich Medical Group Holdings Ltd is an investment holding company. The Company principally engaged in the manufacturing, trading, sales and marketing of medical devices/instruments used for the treatment of coronary and peripheral vascular diseases. The group has only one operating segment. The company has presence in APAC, EMEA, Japan, United States, The PRC, and Others of which majority of revenue comes from APAC.
96GF Score
Get the complete analysis for FRA:Q8T
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:Q8T has been successfully added to your 
